Mainz Biomed to rebrand as Quantum Cyber, shares rise

Quantum Cyber NV

11/03/2026 12:13

** U.S.-listed shares of cancer-focused diagnostic company Mainz Biomed 4TO.F, MYNZ.O jump 28% to $1.07 premarket

** Co to change its name to Quantum Cyber and says its U.S.-listed shares will trade under new ticker QUCY from March 12, pending shareholder approval

** Names former U.S. Homeland Security official Robert Liscouski as chairman

** Adds that it will keep developing pancreatic cancer screening business in the U.S. and is considering selling its colorectal cancer screening assets

** Says it is winding down its German subsidiary and cautions that the plans face regulatory and development risks

** Shares down 26% YTD

 (Reporting by Sahil Pandey in Bengaluru)

 ((Sahil.Pandey@thomsonreuters.com))